Timothy Eisen

4.4k total citations
39 papers, 1.9k citations indexed

About

Timothy Eisen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Timothy Eisen has authored 39 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 15 papers in Oncology. Recurrent topics in Timothy Eisen's work include Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (5 papers). Timothy Eisen is often cited by papers focused on Renal cell carcinoma treatment (15 papers), Cancer Genomics and Diagnostics (7 papers) and Renal and related cancers (5 papers). Timothy Eisen collaborates with scholars based in United Kingdom, United States and France. Timothy Eisen's co-authors include Colin R. Goding, Nicola J. Bentley, Athena Matakidou, Richard S. Houlston, Peter Broderick, Yufei Wang, Jayaram Vijayakrishnan, Christopher I. Amos, Margaret R. Spitz and Emily L. Webb and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Timothy Eisen

38 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Timothy Eisen United Kingdom 19 1.1k 548 458 358 355 39 1.9k
Gabriela Motyckova United States 13 995 0.9× 175 0.3× 408 0.9× 357 1.0× 270 0.8× 19 1.5k
E. Ioachim Greece 24 674 0.6× 171 0.3× 492 1.1× 185 0.5× 317 0.9× 79 1.7k
Yuzo Furuya Japan 22 923 0.8× 731 1.3× 510 1.1× 102 0.3× 359 1.0× 83 1.9k
Raleigh D. Kladney United States 23 996 0.9× 198 0.4× 505 1.1× 258 0.7× 434 1.2× 33 1.8k
Mandy L. Ballinger Australia 25 772 0.7× 237 0.4× 364 0.8× 261 0.7× 428 1.2× 102 1.8k
Linda Xu United States 20 891 0.8× 428 0.8× 264 0.6× 100 0.3× 383 1.1× 27 1.6k
Hiroaki Mita Japan 23 1.5k 1.4× 159 0.3× 502 1.1× 185 0.5× 337 0.9× 52 2.0k
Clyde Riley Australia 23 651 0.6× 186 0.3× 466 1.0× 142 0.4× 250 0.7× 36 1.8k
Peter Horak Germany 20 1.2k 1.1× 242 0.4× 457 1.0× 188 0.5× 590 1.7× 68 1.9k
Laura S. Schmidt United States 20 1.6k 1.4× 1.5k 2.7× 212 0.5× 141 0.4× 573 1.6× 37 2.4k

Countries citing papers authored by Timothy Eisen

Since Specialization
Citations

This map shows the geographic impact of Timothy Eisen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Timothy Eisen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Timothy Eisen more than expected).

Fields of papers citing papers by Timothy Eisen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Timothy Eisen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Timothy Eisen. The network helps show where Timothy Eisen may publish in the future.

Co-authorship network of co-authors of Timothy Eisen

This figure shows the co-authorship network connecting the top 25 collaborators of Timothy Eisen. A scholar is included among the top collaborators of Timothy Eisen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Timothy Eisen. Timothy Eisen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ursprung, Stephan, Andrew N. Priest, Fulvio Zaccagna, et al.. (2021). Multiparametric MRI for assessment of early response to neoadjuvant sunitinib in renal cell carcinoma. PLoS ONE. 16(10). e0258988–e0258988. 4 indexed citations
2.
Ritchie, A.W.S., et al.. (2017). Improving outcomes in high-risk, nonmetastatic renal cancer: new data and ongoing trials. Nature Reviews Urology. 14(12). 753–759. 13 indexed citations
3.
Wang, Yufei, Peter Broderick, Athena Matakidou, et al.. (2011). Variation in TP63 is Associated with Lung Adenocarcinoma in the UK Population. Cancer Epidemiology Biomarkers & Prevention. 20(7). 1453–1462. 20 indexed citations
4.
Wang, Yufei, Peter Broderick, Athena Matakidou, Timothy Eisen, & Richard S. Houlston. (2011). Chromosome 15q25 (CHRNA3-CHRNA5) Variation Impacts Indirectly on Lung Cancer Risk. PLoS ONE. 6(4). e19085–e19085. 22 indexed citations
5.
Bellmunt, Joaquim, Timothy Eisen, Mayer Fishman, & David I. Quinn. (2010). Experience with sorafenib and adverse event management. Critical Reviews in Oncology/Hematology. 78(1). 24–32. 53 indexed citations
6.
Broderick, Peter, Yufei Wang, Jayaram Vijayakrishnan, et al.. (2009). Deciphering the Impact of Common Genetic Variation on Lung Cancer Risk: A Genome-Wide Association Study. Cancer Research. 69(16). 6633–6641. 155 indexed citations
7.
Tuthill, Mark, Ravi Barod, L Pyle, et al.. (2009). A report of succinate dehydrogenase B deficiency associated with metastatic papillary renal cell carcinoma: successful treatment with the multi-targeted tyrosine kinase inhibitor sunitinib. BMJ Case Reports. 2009. bcr0820080732–bcr0820080732. 12 indexed citations
8.
Wang, Yufei, Peter Broderick, Emily L. Webb, et al.. (2008). Common 5p15.33 and 6p21.33 variants influence lung cancer risk. Nature Genetics. 40(12). 1407–1409. 377 indexed citations
9.
Harnden, Patricia, Nermin Ali, Patrick Royston, et al.. (2008). Prognostic factors for renal cell carcinoma. Cancer Treatment Reviews. 34(5). 407–426. 21 indexed citations
10.
Matakidou, Athena, Rachid El Galta, Matthew Rudd, et al.. (2007). Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis. British Journal of Cancer. 96(12). 1904–1907. 36 indexed citations
11.
Staehler, Michael, P.Y. Dietrich, Timothy Eisen, et al.. (2007). A phase I study to evaluate safety, immunogenicity and anti-tumor activity of the multi-peptide vaccine IMA901 in renal cell carcinoma patients (RCC). Journal of Clinical Oncology. 25(18_suppl). 5098–5098. 5 indexed citations
12.
Eisen, Timothy, Ronald M. Bukowski, Michael Staehler, et al.. (2006). Randomized phase III trial of sorafenib in advanced renal cell carcinoma (RCC): Impact of crossover on survival. Journal of Clinical Oncology. 24(18_suppl). 4524–4524. 51 indexed citations
13.
Parton, Marina, N. Maisey, Susana Banerjee, et al.. (2004). Gefitinib in patients with non-small cell lung cancer (NSCLC): The Royal Marsden experience. Journal of Clinical Oncology. 22(14_suppl). 7099–7099. 2 indexed citations
14.
Maisey, N., Kate Hall, Eleni Timotheadou, et al.. (2004). Infliximab: A phase II trial of the tumour necrosis factor (TNFα) monoclonal antibody in patients with advanced renal cell cancer (RCC). Journal of Clinical Oncology. 22(14_suppl). 4514–4514. 14 indexed citations
15.
Rudd, R.M., et al.. (2002). Phase III randomised comparison of gemcitabine and carboplatin (GC) with mitomycin, ifosfamide and cisplatin (MIP) in advanced non-small cell lung cancer (NSCLC). UCL Discovery (University College London). 21 indexed citations
16.
Rudd, R.M., et al.. (2002). A phase III randomised comparison of gemcitabine/carboplatin with mitomycin/ifosfamide/cisplatin in advanced non-small cell lung cancer. UCL Discovery (University College London). 3 indexed citations
17.
Raje, Noopur, R Powles, C Horton, et al.. (1997). Comparison of marrow vs blood-derived stem cells for autografting in previously untreated multiple myeloma. British Journal of Cancer. 75(11). 1684–1689. 18 indexed citations
18.
Mehta, Jayesh, R Powles, Seema Singhal, et al.. (1997). Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts. Bone Marrow Transplantation. 19(4). 349–355. 26 indexed citations
19.
Eisen, Timothy. (1996). The control of gene expression in melanocytes and melanomas. Melanoma Research. 6(4). 277–284. 13 indexed citations
20.
Mehta, Jayesh, R Powles, J Treleaven, et al.. (1996). Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.. PubMed. 18(4). 741–6. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriela Motyckova Breakdown of academic impact, for papers by E. Ioachim Breakdown of academic impact, for papers by Yuzo Furuya Breakdown of academic impact, for papers by Raleigh D. Kladney Breakdown of academic impact, for papers by Mandy L. Ballinger Breakdown of academic impact, for papers by Linda Xu Breakdown of academic impact, for papers by Hiroaki Mita Breakdown of academic impact, for papers by Clyde Riley Breakdown of academic impact, for papers by Peter Horak Breakdown of academic impact, for papers by Laura S. Schmidt
Rankless by CCL
2026